Abiraterone
The serum concentration of Bisoprolol can be increased when it is combined with Abiraterone.
Acebutolol
Bisoprolol may increase the hypotensive activities of Acebutolol.
Aceclofenac
Aceclofenac may decrease the antihypertensive activities of Bisoprolol.
Advertisement
Acemetacin
The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Acemetacin.
Acepromazine
Bisoprolol may increase the orthostatic hypotensive activities of Acepromazine.
Aceprometazine
Aceprometazine may increase the hypotensive activities of Bisoprolol.
Advertisement
Acetohexamide
Bisoprolol may increase the hypoglycemic activities of Acetohexamide.
Acetyl salicylate
Acetylsalicylic acid may decrease the antihypertensive activities of Bisoprolol.
Acetyl Sulfisoxazole
The metabolism of Bisoprolol can be decreased when combined with Acetyl sulfisoxazole.
Advertisement
Acetylcholine
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Acetylcholine.
Acetylcholine Chloride
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Acetylcholine.
Acetyldigitoxin
Bisoprolol may increase the bradycardic activities of Acetyldigitoxin.
Adapalene
Adapalene may decrease the antihypertensive activities of Bisoprolol.
Albuterol
Bisoprolol may decrease the bronchodilatory activities of Salbutamol.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bisoprolol.
Alfentanil
Alfentanil may increase the bradycardic activities of Bisoprolol.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Bisoprolol.
Aliskiren
Bisoprolol may increase the hypotensive activities of Aliskiren.
Alminoprofen
Alminoprofen may decrease the antihypertensive activities of Bisoprolol.
Alprenolol
Bisoprolol may increase the hypotensive activities of Alprenolol.
Ambenonium
Ambenonium may increase the bradycardic activities of Bisoprolol.
Ambrisentan
Bisoprolol may increase the hypotensive activities of Ambrisentan.
AMBROXOL ACEFYLLINATE
Bisoprolol may decrease the bronchodilatory activities of Ambroxol acefyllinate.
Ambroxol-Theophylline-7-Acetate
Bisoprolol may decrease the bronchodilatory activities of Ambroxol acefyllinate.
Amifostine
Bisoprolol may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Bisoprolol may increase the hypotensive activities of Amifostine.
Amiloride
The risk or severity of adverse effects can be increased when Amiloride is combined with Bisoprolol.
Aminophylline
Bisoprolol may decrease the bronchodilatory activities of Aminophylline.
Amiodarone
The therapeutic efficacy of Bisoprolol can be increased when used in combination with Amiodarone.
Amitriptyline
Bisoprolol may increase the orthostatic hypotensive activities of Amitriptyline.
Amlodipine
Amlodipine may increase the hypotensive activities of Bisoprolol.
Amobarbital
The serum concentration of Bisoprolol can be decreased when it is combined with Amobarbital.
Amodiaquine
The metabolism of Bisoprolol can be decreased when combined with Amodiaquine.
Amoxapine
Bisoprolol may increase the orthostatic hypotensive activities of Amoxapine.
Amphetamine
Amphetamine may increase the hypotensive activities of Bisoprolol.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bisoprolol.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bisoprolol.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Amyl Nitrite.
Antipyrine
Antipyrine may decrease the antihypertensive activities of Bisoprolol.
Apalutamide
The serum concentration of Bisoprolol can be decreased when it is combined with Apalutamide.
Apazone
Azapropazone may decrease the antihypertensive activities of Bisoprolol.
Apomorphine
Apomorphine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Apraclonidine
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Apraclonidine.
Apremilast
Apremilast may decrease the antihypertensive activities of Bisoprolol.
Aprepitant
The serum concentration of Bisoprolol can be increased when it is combined with Aprepitant.
Arbutamine
Bisoprolol may decrease the bronchodilatory activities of Arbutamine.
Arformoterol
Bisoprolol may decrease the bronchodilatory activities of Arformoterol.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Bisoprolol.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Bisoprolol.
Artemether
The metabolism of Bisoprolol can be decreased when combined with Artemether.
Asenapine
Bisoprolol may increase the orthostatic hypotensive activities of Asenapine.
Aspirin
Acetylsalicylic acid may decrease the antihypertensive activities of Bisoprolol.
Atazanavir
The metabolism of Bisoprolol can be decreased when combined with Atazanavir.
Atenolol
Atenolol may increase the hypotensive activities of Bisoprolol.
Atomoxetine
The metabolism of Bisoprolol can be decreased when combined with Atomoxetine.
Avanafil
Avanafil may increase the antihypertensive activities of Bisoprolol.
Azelastine
Azelastine may decrease the antihypertensive activities of Bisoprolol.
Azilsartan
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Azilsartan medoxomil.
Balsalazide
Balsalazide may decrease the antihypertensive activities of Bisoprolol.
Bambuterol
Bisoprolol may decrease the bronchodilatory activities of Bambuterol.
Barbexaclone
The serum concentration of Bisoprolol can be decreased when it is combined with Barbexaclone.
Barbital
The serum concentration of Bisoprolol can be decreased when it is combined with Barbital.
Benazepril
Benazepril may increase the hypotensive activities of Bisoprolol.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Bisoprolol.
Benzphetamine
Benzphetamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Benzydamine
Benzydamine may decrease the antihypertensive activities of Bisoprolol.
Bepridil
Bisoprolol may increase the hypotensive activities of Bepridil.
Beractant
Bisoprolol may increase the bradycardic activities of Beractant.
Betaxolol
The metabolism of Bisoprolol can be decreased when combined with Betaxolol.
Bethanechol
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Bethanechol.
Bethanidine
Bethanidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Bimatoprost
Bisoprolol may increase the hypotensive activities of Bimatoprost.
Bitolterol
Bisoprolol may decrease the bronchodilatory activities of Bitolterol.
Bitolterol Mesylate
Bisoprolol may decrease the bronchodilatory activities of Bitolterol.
Boceprevir
The metabolism of Bisoprolol can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Bisoprolol can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Bisoprolol can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Bisoprolol can be decreased when it is combined with Bosentan.
Bretylium
Bretylium may increase the bradycardic activities of Bisoprolol.
Brexpiprazole
Bisoprolol may increase the orthostatic hypotensive activities of Brexpiprazole.
Brimonidine
Brimonidine may increase the antihypertensive activities of Bisoprolol.
Bromfenac
Bromfenac may decrease the antihypertensive activities of Bisoprolol.
Bromocriptine
Bromocriptine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Bufexamac
Bufexamac may decrease the antihypertensive activities of Bisoprolol.
Bumetanide
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Bumetanide.
Bunazosin
Bisoprolol may increase the orthostatic hypotensive activities of Bunazosin.
Bupivacaine
The serum concentration of Bupivacaine can be increased when it is combined with Bisoprolol.
Bupranolol
Bisoprolol may increase the hypotensive activities of Bupranolol.
Bupropion
The metabolism of Bisoprolol can be decreased when combined with Bupropion.
Cabergoline
Bisoprolol may increase the vasoconstricting activities of Cabergoline.
Cafedrine
Bisoprolol may increase the hypotensive activities of Cafedrine.
Calfactant
Bisoprolol may increase the bradycardic activities of Calfactant.
Canagliflozin
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Canagliflozin.
Candesartan
Bisoprolol may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Bisoprolol may increase the hypotensive activities of Candesartan cilexetil.
Captopril
Bisoprolol may increase the hypotensive activities of Captopril.
Carbachol
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Carbachol.
Carbamazepine
The metabolism of Bisoprolol can be increased when combined with Carbamazepine.
Carprofen
Carprofen may decrease the antihypertensive activities of Bisoprolol.
Carteolol
Carteolol may increase the hypotensive activities of Bisoprolol.
Carvedilol
Bisoprolol may increase the orthostatic hypotensive activities of Carvedilol.
Celecoxib
The metabolism of Bisoprolol can be decreased when combined with Celecoxib.
Celiprolol
Bisoprolol may increase the hypotensive activities of Celiprolol.
Ceritinib
Bisoprolol may increase the bradycardic activities of Ceritinib.
Cevimeline
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Cevimeline.
Chloroquine
The metabolism of Bisoprolol can be decreased when combined with Chloroquine.
Chlorothiazide
Bisoprolol may increase the hypotensive activities of Chlorothiazide.
Chlorpromazine
Bisoprolol may increase the orthostatic hypotensive activities of Chlorpromazine.
Chlorpropamide
Bisoprolol may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Bisoprolol.
Cholecalciferol
The metabolism of Bisoprolol can be decreased when combined with Cholecalciferol.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may decrease the antihypertensive activities of Bisoprolol.
Cicletanine
Bisoprolol may increase the hypotensive activities of Cicletanine.
Cilazapril
Bisoprolol may increase the hypotensive activities of Cilazapril.
Cimetidine
The metabolism of Bisoprolol can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Bisoprolol can be decreased when combined with Cinacalcet.
Citalopram
The metabolism of Bisoprolol can be decreased when combined with Citalopram.
Clarithromycin
The metabolism of Bisoprolol can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Bisoprolol can be decreased when combined with Clemastine.
Clenbuterol
Bisoprolol may decrease the bronchodilatory activities of Clenbuterol.
Clevidipine
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Clevidipine.
Clobazam
The metabolism of Bisoprolol can be decreased when combined with Clobazam.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Bisoprolol.
Clomipramine
The metabolism of Bisoprolol can be decreased when combined with Clomipramine.
Clonidine
Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Clonixin
Clonixin may decrease the antihypertensive activities of Bisoprolol.
Clotrimazole
The metabolism of Bisoprolol can be decreased when combined with Clotrimazole.
Clozapine
Bisoprolol may increase the orthostatic hypotensive activities of Clozapine.
Cobicistat
The serum concentration of Bisoprolol can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Bisoprolol can be decreased when combined with Cocaine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Bisoprolol.
Crizotinib
The metabolism of Bisoprolol can be decreased when combined with Crizotinib.
Cryptenamine
Bisoprolol may increase the hypotensive activities of Cryptenamine.
Curcumin
The metabolism of Bisoprolol can be decreased when combined with Curcumin.
Cyclopenthiazide
Bisoprolol may increase the hypotensive activities of Cyclopenthiazide.
Cyclosporine
The metabolism of Bisoprolol can be decreased when combined with Cyclosporine.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Bisoprolol.
Dabrafenib
The serum concentration of Bisoprolol can be decreased when it is combined with Dabrafenib.
Dapagliflozin
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Dapagliflozin.
Dapiprazole
Bisoprolol may increase the orthostatic hypotensive activities of Dapiprazole.
Darifenacin
The metabolism of Bisoprolol can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Bisoprolol can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Bisoprolol can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Bisoprolol can be increased when it is combined with Dasatinib.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Bisoprolol.
Deferasirox
The serum concentration of Bisoprolol can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Bisoprolol can be decreased when combined with Delavirdine.
Demecarium
Demecarium may increase the bradycardic activities of Bisoprolol.
Deserpidine
Bisoprolol may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Bisoprolol.
Desipramine
The metabolism of Bisoprolol can be decreased when combined with Desipramine.
Deslanoside
Bisoprolol may increase the bradycardic activities of Deslanoside.
Desvenlafaxine
The serum concentration of Bisoprolol can be increased when it is combined with Desvenlafaxine.
Dexmedetomidine
Dexmedetomidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Dextroamphetamine
Bisoprolol may increase the orthostatic hypotensive activities of Dextroamphetamine.
Diazoxide
Diazoxide may increase the hypotensive activities of Bisoprolol.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Diclofenamide.
Diclofenac
Diclofenac may decrease the antihypertensive activities of Bisoprolol.
Diflunisal
Diflunisal may decrease the antihypertensive activities of Bisoprolol.
Digitoxin
Bisoprolol may increase the bradycardic activities of Digitoxin.
Digoxin
Bisoprolol may increase the bradycardic activities of Digoxin.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Bisoprolol.
Dihydroergotamine
Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Diltiazem
The metabolism of Bisoprolol can be decreased when combined with Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Dinutuximab.
Diphenhydramine
The metabolism of Bisoprolol can be decreased when combined with Diphenhydramine.
Dipivefrin
Dipivefrin may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Dipyridamole
Dipyridamole may increase the bradycardic activities of Bisoprolol.
Dipyrone
Metamizole may decrease the antihypertensive activities of Bisoprolol.
Disopyramide
Disopyramide may increase the bradycardic activities of Bisoprolol.
Distigmine
Distigmine may increase the bradycardic activities of Bisoprolol.
Dobutamine
Bisoprolol may decrease the bronchodilatory activities of Dobutamine.
Donepezil
Donepezil may increase the bradycardic activities of Bisoprolol.
Dorzolamide
Bisoprolol may increase the hypotensive activities of Dorzolamide.
Dothiepin
The metabolism of Bisoprolol can be decreased when combined with Dosulepin.
Doxazosin
Bisoprolol may increase the orthostatic hypotensive activities of Doxazosin.
Doxepin
Bisoprolol may increase the orthostatic hypotensive activities of Doxepin.
Doxycycline
The metabolism of Bisoprolol can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Bisoprolol can be decreased when combined with Doxycycline.
Dronedarone
Dronedarone may increase the bradycardic activities of Bisoprolol.
Droperidol
Bisoprolol may increase the orthostatic hypotensive activities of Droperidol.
Droxicam
Droxicam may decrease the antihypertensive activities of Bisoprolol.
Droxidopa
Droxidopa may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Duloxetine
Bisoprolol may increase the orthostatic hypotensive activities of Duloxetine.
Dyphylline
Bisoprolol may decrease the bronchodilatory activities of Dyphylline.
Echothiophate
Echothiophate may increase the bradycardic activities of Bisoprolol.
Edrophonium
Edrophonium may increase the bradycardic activities of Bisoprolol.
Eliglustat
The metabolism of Bisoprolol can be decreased when combined with Eliglustat.
Empagliflozin
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Empagliflozin.
Enalapril
Enalapril may increase the hypotensive activities of Bisoprolol.
Enalaprilat
Bisoprolol may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Bisoprolol may increase the hypotensive activities of Enalaprilat.
Enzalutamide
The serum concentration of Bisoprolol can be decreased when it is combined with Enzalutamide.
Epinephrine
Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Eplerenone
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Eplerenone.
Epoprostenol
Bisoprolol may increase the hypotensive activities of Epoprostenol.
Eprosartan
Bisoprolol may increase the hypotensive activities of Eprosartan.
ergoloid mesylates, USP
Bisoprolol may increase the vasoconstricting activities of Ergoloid mesylate.
Ergonovine
Bisoprolol may increase the vasoconstricting activities of Ergonovine.
Ergotamine
Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Erythromycin
The metabolism of Bisoprolol can be decreased when combined with Erythromycin.
Escitalopram
Bisoprolol may increase the orthostatic hypotensive activities of Escitalopram.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Bisoprolol.
Etanercept
Etanercept may decrease the antihypertensive activities of Bisoprolol.
Ethacrynate
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Etacrynic acid.
Etodolac
Etodolac may decrease the antihypertensive activities of Bisoprolol.
Etofenamate
Etofenamate may decrease the antihypertensive activities of Bisoprolol.
Etomidate
Etomidate may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Etoricoxib
Etoricoxib may decrease the antihypertensive activities of Bisoprolol.
Evening primrose oil
Evening primrose oil may decrease the antihypertensive activities of Bisoprolol.
Felbinac
Felbinac may decrease the antihypertensive activities of Bisoprolol.
Felodipine
Bisoprolol may increase the hypotensive activities of Felodipine.
Fenbufen
Fenbufen may decrease the antihypertensive activities of Bisoprolol.
Fenoldopam
Bisoprolol may increase the hypotensive activities of Fenoldopam.
Fenoprofen
Fenoprofen may decrease the antihypertensive activities of Bisoprolol.
Fenoterol
Bisoprolol may decrease the bronchodilatory activities of Fenoterol.
Fentanyl
Fentanyl may increase the bradycardic activities of Bisoprolol.
Ferulic Acid
Bisoprolol may increase the hypotensive activities of Ferulic acid.
Fingolimod
Bisoprolol may increase the bradycardic activities of Fingolimod.
Floctafenine
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Floctafenine.
Fluconazole
The metabolism of Bisoprolol can be decreased when combined with Fluconazole.
Fluoxetine
The metabolism of Bisoprolol can be decreased when combined with Fluoxetine.
Flupenthixol
Bisoprolol may increase the orthostatic hypotensive activities of Flupentixol.
Fluphenazine
Fluphenazine may increase the hypotensive activities of Bisoprolol.
Flurbiprofen
Flurbiprofen may decrease the antihypertensive activities of Bisoprolol.
Fluvoxamine
The metabolism of Bisoprolol can be decreased when combined with Fluvoxamine.
Formoterol
Bisoprolol may decrease the bronchodilatory activities of Formoterol.
Fosamprenavir
The metabolism of Bisoprolol can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Bisoprolol can be increased when it is combined with Fosaprepitant.
Fosinopril
Fosinopril may increase the hypotensive activities of Bisoprolol.
Fosphenytoin
The metabolism of Bisoprolol can be increased when combined with Fosphenytoin.
Fostamatinib
Fostamatinib may increase the antihypertensive activities of Bisoprolol.
Furazolidone
Furazolidone may increase the hypotensive activities of Bisoprolol.
Furosemide
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Furosemide.
Fusidate
The serum concentration of Bisoprolol can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Bisoprolol can be increased when it is combined with Fusidic Acid.
Galantamine
Galantamine may increase the bradycardic activities of Bisoprolol.
Gallamine Triethiodide
Gallamine Triethiodide may increase the bradycardic activities of Bisoprolol.
Ginkgo biloba extract
Ginkgo biloba may increase the bradycardic activities of Bisoprolol.
Glibornuride
Bisoprolol may increase the hypoglycemic activities of Glibornuride.
Gliclazide
Bisoprolol may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Bisoprolol may increase the hypoglycemic activities of Glimepiride.
Glipizide
Bisoprolol may increase the hypoglycemic activities of Glipizide.
Gliquidone
Bisoprolol may increase the hypoglycemic activities of Gliquidone.
Glyburide
Bisoprolol may increase the hypoglycemic activities of Glyburide.
Guanabenz
Guanabenz may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Guanadrel
Guanadrel may increase the hypotensive activities of Bisoprolol.
Guanethidine
Bisoprolol may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Haloperidol
The metabolism of Bisoprolol can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Bisoprolol.
Hexobarbital
The serum concentration of Bisoprolol can be decreased when it is combined with Hexobarbital.
Hexoprenaline
Bisoprolol may decrease the bronchodilatory activities of Hexoprenaline.
Hydralazine
Hydralazine may increase the hypotensive activities of Bisoprolol.
Hydrochlorothiazide
Bisoprolol may increase the hypotensive activities of Hydrochlorothiazide.
Hydroflumethiazide
Bisoprolol may increase the hypotensive activities of Hydroflumethiazide.
Hydroxychloroquine
The metabolism of Bisoprolol can be decreased when combined with Hydroxychloroquine.
Hypoxis hemerocallidea root extract
The serum concentration of Bisoprolol can be decreased when it is combined with St. John's Wort.
Ibuprofen
Ibuprofen may decrease the antihypertensive activities of Bisoprolol.
Icatibant
Icatibant may decrease the antihypertensive activities of Bisoprolol.
Idelalisib
The metabolism of Bisoprolol can be decreased when combined with Idelalisib.
Iloperidone
Bisoprolol may increase the orthostatic hypotensive activities of Iloperidone.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Bisoprolol.
Imatinib
The metabolism of Bisoprolol can be decreased when combined with Imatinib.
Imidapril
Bisoprolol may increase the hypotensive activities of Imidapril.
Imipramine
Bisoprolol may increase the orthostatic hypotensive activities of Imipramine.
Indacaterol
Bisoprolol may decrease the bronchodilatory activities of Indacaterol.
Indapamide
Bisoprolol may increase the hypotensive activities of Indapamide.
Indinavir
The metabolism of Bisoprolol can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Bisoprolol can be decreased when combined with Indinavir.
Indobufen
Indobufen may decrease the antihypertensive activities of Bisoprolol.
Indomethacin
Indomethacin may decrease the antihypertensive activities of Bisoprolol.
Indoramin
Bisoprolol may increase the orthostatic hypotensive activities of Indoramin.
insulin human, rDNA origin
Bisoprolol may increase the hypoglycemic activities of Insulin Human.
Insulin, Pork
Bisoprolol may increase the hypoglycemic activities of Insulin Pork.
Insulin, Regular, Pork
Bisoprolol may increase the hypoglycemic activities of Insulin Pork.
Iproniazid
Iproniazid may increase the hypotensive activities of Bisoprolol.
Irbesartan
Bisoprolol may increase the hypotensive activities of Irbesartan.
Isavuconazole
The serum concentration of Bisoprolol can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Bisoprolol can be decreased when combined with Isavuconazonium.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Bisoprolol.
Isoetharine
Bisoprolol may decrease the bronchodilatory activities of Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Bisoprolol.
Isoflurophate
Isoflurophate may increase the bradycardic activities of Bisoprolol.
Isoniazid
The metabolism of Bisoprolol can be decreased when combined with Isoniazid.
Isoproterenol
Bisoprolol may decrease the bronchodilatory activities of Isoprenaline.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Isoxsuprine.
Isradipine
The metabolism of Bisoprolol can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Bisoprolol can be decreased when combined with Itraconazole.
Ivabradine
Bisoprolol may increase the bradycardic activities of Ivabradine.
Ivacaftor
The serum concentration of Bisoprolol can be increased when it is combined with Ivacaftor.
Kebuzone
Kebuzone may decrease the antihypertensive activities of Bisoprolol.
Ketanserin
Ketanserin may increase the hypotensive activities of Bisoprolol.
Ketoconazole
The metabolism of Bisoprolol can be decreased when combined with Ketoconazole.
Ketoprofen
Ketoprofen may decrease the antihypertensive activities of Bisoprolol.
Ketorolac
Ketorolac may decrease the antihypertensive activities of Bisoprolol.
Labetalol
Bisoprolol may increase the orthostatic hypotensive activities of Labetalol.
Lacidipine
Bisoprolol may increase the hypotensive activities of Lacidipine.
Lacosamide
Bisoprolol may increase the atrioventricular blocking (AV block) activities of Lacosamide.
Lanreotide
Bisoprolol may increase the bradycardic activities of Lanreotide.
Latanoprost
Bisoprolol may increase the hypotensive activities of Latanoprost.
Leflunomide
Leflunomide may decrease the antihypertensive activities of Bisoprolol.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Bisoprolol.
Levalbuterol
Bisoprolol may decrease the bronchodilatory activities of Levosalbutamol.
Levobunolol
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Bisoprolol.
Levodopa
Bisoprolol may increase the orthostatic hypotensive activities of Levodopa.
Levomilnacipran
The serum concentration of Bisoprolol can be increased when it is combined with Levomilnacipran.
Levonordefrin
Levonordefrin may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Bisoprolol.
Lidocaine
The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.
Limonene, (+)-
(4R)-limonene may decrease the antihypertensive activities of Bisoprolol.
Lisdexamfetamine
Bisoprolol may increase the orthostatic hypotensive activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Bisoprolol may increase the orthostatic hypotensive activities of Lisdexamfetamine.
Lisinopril
Bisoprolol may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Bisoprolol may increase the hypotensive activities of Lisinopril.
Lobeline
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Lobeline.
Lofexidine
Lofexidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Lopinavir
The metabolism of Bisoprolol can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Bisoprolol can be decreased when combined with Lorcaserin.
Lornoxicam
Lornoxicam may decrease the antihypertensive activities of Bisoprolol.
Losartan
Bisoprolol may increase the hypotensive activities of Losartan.
Lovastatin
The metabolism of Bisoprolol can be decreased when combined with Lovastatin.
Loxoprofen
Loxoprofen may decrease the antihypertensive activities of Bisoprolol.
Lucinactant
Bisoprolol may increase the bradycardic activities of Lucinactant.
Luliconazole
The serum concentration of Bisoprolol can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Bisoprolol can be increased when combined with Lumacaftor.
Lumefantrine
The metabolism of Bisoprolol can be decreased when combined with Lumefantrine.
Macitentan
Bisoprolol may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
Magnesium salicylate may decrease the antihypertensive activities of Bisoprolol.
Malathion
Malathion may increase the bradycardic activities of Bisoprolol.
Manidipine
Bisoprolol may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Mannitol.
Masoprocol
Masoprocol may decrease the antihypertensive activities of Bisoprolol.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Bisoprolol.
Meclofenamate
Meclofenamic acid may decrease the antihypertensive activities of Bisoprolol.
Meclofenamic Acid
Meclofenamic acid may decrease the antihypertensive activities of Bisoprolol.
Mefenamic Acid
Mefenamic acid may decrease the antihypertensive activities of Bisoprolol.
Mefloquine
Mefloquine may increase the bradycardic activities of Bisoprolol.
Meloxicam
Meloxicam may decrease the antihypertensive activities of Bisoprolol.
Memantine
Memantine may increase the bradycardic activities of Bisoprolol.
Mephobarbital
The serum concentration of Bisoprolol can be decreased when it is combined with Methylphenobarbital.
Mepirodipine
Bisoprolol may increase the antihypertensive activities of Barnidipine.
Mepivacaine
The serum concentration of Mepivacaine can be increased when it is combined with Bisoprolol.
Mesalamine
Mesalazine may decrease the antihypertensive activities of Bisoprolol.
Mesoridazine
Mesoridazine may increase the hypotensive activities of Bisoprolol.
Metaproterenol
Bisoprolol may decrease the bronchodilatory activities of Orciprenaline.
Methacholine
Bisoprolol may increase the bronchoconstrictory activities of Methacholine.
Methadone
The metabolism of Bisoprolol can be decreased when combined with Methadone.
Methamphetamine
Methamphetamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Methazolamide
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Methazolamide.
Methohexital
The serum concentration of Bisoprolol can be decreased when it is combined with Methohexital.
Methotrimeprazine
The metabolism of Bisoprolol can be decreased when combined with Methotrimeprazine.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Bisoprolol.
Methyldopa
Methyldopa may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
METHYLDOPA ANHYDROUS
Methyldopa may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Methylene blue
Methylene blue may increase the hypotensive activities of Bisoprolol.
METHYLEPHEDRINE, DL-
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Methylergonovine
Bisoprolol may increase the vasoconstricting activities of Methylergometrine.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Bisoprolol.
Metipranolol
Bisoprolol may increase the hypotensive activities of Metipranolol.
Metoclopramide
Metoclopramide may increase the bradycardic activities of Bisoprolol.
Metolazone
Metolazone may increase the hypotensive activities of Bisoprolol.
Metoprolol
The metabolism of Bisoprolol can be decreased when combined with Metoprolol.
Metyrosine
Bisoprolol may increase the hypotensive activities of Metyrosine.
Mibefradil
Bisoprolol may increase the hypotensive activities of Mibefradil.
Midodrine
Bisoprolol may increase the bradycardic activities of Midodrine.
Midostaurin
The metabolism of Bisoprolol can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Bisoprolol can be increased when it is combined with Mifepristone.
Milnacipran
The serum concentration of Bisoprolol can be increased when it is combined with Milnacipran.
Minaprine
Minaprine may increase the bradycardic activities of Bisoprolol.
Minoxidil
Minoxidil may increase the hypotensive activities of Bisoprolol.
Mirabegron
The metabolism of Bisoprolol can be decreased when combined with Mirabegron.
Mitotane
The serum concentration of Bisoprolol can be decreased when it is combined with Mitotane.
Moclobemide
Moclobemide may increase the hypotensive activities of Bisoprolol.
Moexipril
Bisoprolol may increase the hypotensive activities of Moexipril.
Molsidomine
Molsidomine may increase the hypotensive activities of Bisoprolol.
Moricizine
Moricizine may increase the hypotensive activities of Bisoprolol.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Bisoprolol.
Moxonidine
Moxonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
MYCOPHENOLATE
Mycophenolic acid may decrease the antihypertensive activities of Bisoprolol.
Mycophenolate Mofetil
Mycophenolate mofetil may decrease the antihypertensive activities of Bisoprolol.
Mycophenolic Acid
Mycophenolic acid may decrease the antihypertensive activities of Bisoprolol.
N-methylephedrine
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Bisoprolol.
Nabumetone
Nabumetone may decrease the antihypertensive activities of Bisoprolol.
Nadolol
Bisoprolol may increase the hypotensive activities of Nadolol.
Naftifine
Naftifine may decrease the antihypertensive activities of Bisoprolol.
Naphazoline
Naphazoline may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Naproxen
Naproxen may decrease the antihypertensive activities of Bisoprolol.
Nebivolol
Bisoprolol may increase the hypotensive activities of Nebivolol.
Nefazodone
The metabolism of Bisoprolol can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Bisoprolol can be decreased when combined with Nelfinavir.
Neostigmine
Neostigmine may increase the bradycardic activities of Bisoprolol.
Nepafenac
Nepafenac may decrease the antihypertensive activities of Bisoprolol.
Nesiritide
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nesiritide.
Netupitant
The serum concentration of Bisoprolol can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Bisoprolol can be increased when combined with Nevirapine.
Nialamide
Nialamide may increase the hypotensive activities of Bisoprolol.
Nicardipine
Bisoprolol may increase the orthostatic hypotensive activities of Nicardipine.
Nicergoline
Bisoprolol may increase the orthostatic hypotensive activities of Nicergoline.
Nicorandil
Nicorandil may increase the hypotensive activities of Bisoprolol.
Nicotine
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nicotine.
Nicotine Polacrilex
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nicotine.
Nifedipine
The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Bisoprolol.
Niflumic Acid
Niflumic Acid may decrease the antihypertensive activities of Bisoprolol.
Nilotinib
The metabolism of Bisoprolol can be decreased when combined with Nilotinib.
Nilvadipine
Bisoprolol may increase the hypotensive activities of Nilvadipine.
Nimesulide
Nimesulide may decrease the antihypertensive activities of Bisoprolol.
Nimodipine
Nimodipine may increase the hypotensive activities of Bisoprolol.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Bisoprolol.
Nitrendipine
Bisoprolol may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Bisoprolol.
Nitroglycerin
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nitroglycerin.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Bisoprolol.
Norepinephrine
Norepinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Nortriptyline
Bisoprolol may increase the orthostatic hypotensive activities of Nortriptyline.
O-PHENANTHROLINE
1,10-Phenanthroline may increase the bradycardic activities of Bisoprolol.
Obinutuzumab
Bisoprolol may increase the hypotensive activities of Obinutuzumab.
Octreotide
Octreotide may increase the bradycardic activities of Bisoprolol.
Oenothera biennis seed extract
Evening primrose oil may decrease the antihypertensive activities of Bisoprolol.
Olanzapine
Bisoprolol may increase the orthostatic hypotensive activities of Olanzapine.
Olaparib
The metabolism of Bisoprolol can be decreased when combined with Olaparib.
Olmesartan
Olmesartan may increase the hypotensive activities of Bisoprolol.
Olodaterol
Bisoprolol may decrease the bronchodilatory activities of Olodaterol.
Olopatadine
Olopatadine may decrease the antihypertensive activities of Bisoprolol.
Olsalazine
Olsalazine may decrease the antihypertensive activities of Bisoprolol.
Osimertinib
The serum concentration of Bisoprolol can be increased when it is combined with Osimertinib.
Ouabain
Bisoprolol may increase the bradycardic activities of Ouabain.
Ovine Digoxin Immune Fab
Bisoprolol may increase the bradycardic activities of Digoxin Immune Fab (Ovine).
Oxaprozin
Oxaprozin may decrease the antihypertensive activities of Bisoprolol.
Oxprenolol
Bisoprolol may increase the hypotensive activities of Oxprenolol.
Oxymetazoline
Oxymetazoline may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Oxyphenbutazone
Oxyphenbutazone may decrease the antihypertensive activities of Bisoprolol.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Bisoprolol.
Palbociclib
The serum concentration of Bisoprolol can be increased when it is combined with Palbociclib.
Paliperidone
Paliperidone may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Palmidrol
Palmidrol may decrease the antihypertensive activities of Bisoprolol.
Panobinostat
The serum concentration of Bisoprolol can be increased when it is combined with Panobinostat.
Papaverine
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Papaverine.
Parecoxib
Parecoxib may decrease the antihypertensive activities of Bisoprolol.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Bisoprolol.
Pargyline
Pargyline may increase the hypotensive activities of Bisoprolol.
Paroxetine
The metabolism of Bisoprolol can be decreased when combined with Paroxetine.
Parthenolide
Parthenolide may decrease the antihypertensive activities of Bisoprolol.
Pasireotide
Bisoprolol may increase the bradycardic activities of Pasireotide.
Peginterferon Alfa-2b
The serum concentration of Bisoprolol can be decreased when it is combined with Peginterferon alfa-2b.
Penbutolol
Bisoprolol may increase the hypotensive activities of Penbutolol.
Pentobarbital
The metabolism of Bisoprolol can be increased when combined with Pentobarbital.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Bisoprolol.
Perazine
Perazine may increase the hypotensive activities of Bisoprolol.
Pergolide
Pergolide may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Periciazine
Bisoprolol may increase the orthostatic hypotensive activities of Propericiazine.
Perindopril
Bisoprolol may increase the hypotensive activities of Perindopril.
Perphenazine
Perphenazine may increase the hypotensive activities of Bisoprolol.
Phenelzine
Phenelzine may increase the hypotensive activities of Bisoprolol.
Phenobarbital
The metabolism of Bisoprolol can be increased when combined with Phenobarbital.
Phenoxybenzamine
Bisoprolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.
Phentolamine
Bisoprolol may increase the orthostatic hypotensive activities of Phentolamine.
Phentolamine Mesylate
Bisoprolol may increase the orthostatic hypotensive activities of Phentolamine.
Phenylbutazone
Phenylbutazone may decrease the antihypertensive activities of Bisoprolol.
Phenylpropanolamine
Bisoprolol may decrease the bronchodilatory activities of Phenylpropanolamine.
Phenytoin
The metabolism of Bisoprolol can be increased when combined with Phenytoin.
Physostigmine
Physostigmine may increase the bradycardic activities of Bisoprolol.
Pilocarpine
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Pilocarpine.
Pimecrolimus
Pimecrolimus may decrease the antihypertensive activities of Bisoprolol.
Pinacidil
Pinacidil may increase the hypotensive activities of Bisoprolol.
Pindolol
Bisoprolol may increase the hypotensive activities of Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Bisoprolol.
Pirbuterol
Bisoprolol may decrease the bronchodilatory activities of Pirbuterol.
Pirfenidone
Pirfenidone may decrease the antihypertensive activities of Bisoprolol.
Piroxicam
Piroxicam may decrease the antihypertensive activities of Bisoprolol.
Piroxicam-Beta-Cyclodextrin
Piroxicam may decrease the antihypertensive activities of Bisoprolol.
Pizotyline
Bisoprolol may increase the orthostatic hypotensive activities of Pizotifen.
Polythiazide
Bisoprolol may increase the hypotensive activities of Polythiazide.
Poractant alfa
Bisoprolol may increase the bradycardic activities of Poractant alfa.
Posaconazole
The metabolism of Bisoprolol can be decreased when combined with Posaconazole.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Bisoprolol.
Prazosin
Bisoprolol may increase the orthostatic hypotensive activities of Prazosin.
Primaquine
The metabolism of Bisoprolol can be decreased when combined with Primaquine.
Primidone
The metabolism of Bisoprolol can be increased when combined with Primidone.
Procaine
Procaine may increase the hypotensive activities of Bisoprolol.
Procarbazine
Procarbazine may increase the hypotensive activities of Bisoprolol.
Procaterol
Bisoprolol may decrease the bronchodilatory activities of Procaterol.
Prochlorperazine
Prochlorperazine may increase the hypotensive activities of Bisoprolol.
Promazine
Bisoprolol may increase the orthostatic hypotensive activities of Promazine.
Promethazine
Promethazine may increase the hypotensive activities of Bisoprolol.
Propafenone
The serum concentration of Bisoprolol can be increased when it is combined with Propafenone.
Propiomazine
Bisoprolol may increase the orthostatic hypotensive activities of Propiomazine.
Propiverine
Bisoprolol may increase the orthostatic hypotensive activities of Propiverine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Bisoprolol.
Propranolol
Propranolol may increase the hypotensive activities of Bisoprolol.
Proscillaridin
Bisoprolol may increase the bradycardic activities of Proscillaridin.
Pseudoephedrine
Pseudoephedrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Pyridostigmine
Pyridostigmine may increase the bradycardic activities of Bisoprolol.
Pyridostigmine Bromide
Pyridostigmine may increase the bradycardic activities of Bisoprolol.
Quetiapine
Bisoprolol may increase the orthostatic hypotensive activities of Quetiapine.
Quetiapine fumarate
Bisoprolol may increase the orthostatic hypotensive activities of Quetiapine.
Quinapril
Bisoprolol may increase the hypotensive activities of Quinapril.
Quinidine
The metabolism of Bisoprolol can be decreased when combined with Quinidine.
Quinine
The metabolism of Bisoprolol can be decreased when combined with Quinine.
Racepinephrine
Racepinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Ramipril
Ramipril may increase the hypotensive activities of Bisoprolol.
Ranolazine
The metabolism of Bisoprolol can be decreased when combined with Ranolazine.
Rasagiline
Rasagiline may increase the hypotensive activities of Bisoprolol.
Regorafenib
Regorafenib may increase the bradycardic activities of Bisoprolol.
Regular Insulin, Human
Bisoprolol may increase the hypoglycemic activities of Insulin Human.
Remifentanil
Remifentanil may increase the bradycardic activities of Bisoprolol.
Rescinnamine
Bisoprolol may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Bisoprolol.
Resveratrol
Resveratrol may decrease the antihypertensive activities of Bisoprolol.
Rifabutin
The metabolism of Bisoprolol can be increased when combined with Rifabutin.
Rifampin
The metabolism of Bisoprolol can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Bisoprolol can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Bisoprolol can be decreased when it is combined with Rifaximin.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Bisoprolol.
Riociguat
Bisoprolol may increase the hypotensive activities of Riociguat.
Risperidone
Bisoprolol may increase the hypotensive activities of Risperidone.
Ritodrine
Bisoprolol may decrease the bronchodilatory activities of Ritodrine.
Ritonavir
The metabolism of Bisoprolol can be decreased when combined with Ritonavir.
Rituximab
Bisoprolol may increase the hypotensive activities of Rituximab.
Rivastigmine
Bisoprolol may increase the bradycardic activities of Rivastigmine.
Rofecoxib
Rofecoxib may decrease the antihypertensive activities of Bisoprolol.
Rolapitant
The metabolism of Bisoprolol can be decreased when combined with Rolapitant.
Ropinirole
Ropinirole may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Bisoprolol.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Bisoprolol.
Rucaparib
The metabolism of Bisoprolol can be decreased when combined with Rucaparib.
Ruxolitinib
Ruxolitinib may increase the bradycardic activities of Bisoprolol.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Bisoprolol.
Salicylamide
Salicylamide may decrease the antihypertensive activities of Bisoprolol.
Salicylic Acid
Salicylic acid may decrease the antihypertensive activities of Bisoprolol.
Salmeterol
Bisoprolol may decrease the bronchodilatory activities of Salmeterol.
Salsalate
Salsalate may decrease the antihypertensive activities of Bisoprolol.
Saquinavir
The metabolism of Bisoprolol can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Bisoprolol can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Sarilumab.
Secobarbital
The serum concentration of Bisoprolol can be decreased when it is combined with Secobarbital.
Selegiline
Selegiline may increase the hypotensive activities of Bisoprolol.
Selexipag
Bisoprolol may increase the hypotensive activities of Selexipag.
Serratiopeptidase
Serrapeptase may decrease the antihypertensive activities of Bisoprolol.
Sertraline
The metabolism of Bisoprolol can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Bisoprolol.
Sildenafil
Sildenafil may increase the antihypertensive activities of Bisoprolol.
Silodosin
Bisoprolol may increase the orthostatic hypotensive activities of Silodosin.
Siltuximab
The serum concentration of Bisoprolol can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Bisoprolol can be increased when it is combined with Simeprevir.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Bisoprolol.
Spirapril
Bisoprolol may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Bisoprolol.
ST. JOHN'S WORT EXTRACT
The serum concentration of Bisoprolol can be decreased when it is combined with St. John's Wort.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Bisoprolol.
Sufentanil
Sufentanil may increase the bradycardic activities of Bisoprolol.
Sulfasalazine
Sulfasalazine may decrease the antihypertensive activities of Bisoprolol.
Sulfisoxazole
The metabolism of Bisoprolol can be decreased when combined with Sulfisoxazole.
Sulindac
Sulindac may decrease the antihypertensive activities of Bisoprolol.
Suprofen
Suprofen may decrease the antihypertensive activities of Bisoprolol.
Tacrine
Tacrine may increase the bradycardic activities of Bisoprolol.
Tadalafil
Tadalafil may increase the antihypertensive activities of Bisoprolol.
Talinolol
Bisoprolol may increase the hypotensive activities of Talinolol.
Tamsulosin
Bisoprolol may increase the orthostatic hypotensive activities of Tamsulosin.
Telaprevir
The metabolism of Bisoprolol can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Bisoprolol can be decreased when combined with Telithromycin.
Telmisartan
Bisoprolol may increase the hypotensive activities of Telmisartan.
Tenoxicam
Tenoxicam may decrease the antihypertensive activities of Bisoprolol.
Terazosin
Bisoprolol may increase the orthostatic hypotensive activities of Terazosin.
Terbinafine
The metabolism of Bisoprolol can be decreased when combined with Terbinafine.
Terbutaline
Bisoprolol may decrease the bronchodilatory activities of Terbutaline.
Terbutaline Sulfate
Bisoprolol may decrease the bronchodilatory activities of Terbutaline.
Teriflunomide
Teriflunomide may decrease the antihypertensive activities of Bisoprolol.
Terlipressin
Bisoprolol may increase the hypotensive activities of Terlipressin.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Bisoprolol.
Theodrenaline
Bisoprolol may increase the hypotensive activities of Theodrenaline.
Theophylline
Bisoprolol may decrease the bronchodilatory activities of Theophylline.
Theophylline anhydrous
Bisoprolol may decrease the bronchodilatory activities of Theophylline.
Thiamylal
The serum concentration of Bisoprolol can be decreased when it is combined with Thiamylal.
Thiethylperazine
Thiethylperazine may increase the hypotensive activities of Bisoprolol.
Thiopental
The serum concentration of Bisoprolol can be decreased when it is combined with Thiopental.
Thiopental Sodium
The serum concentration of Bisoprolol can be decreased when it is combined with Thiopental.
Thioproperazine
Bisoprolol may increase the orthostatic hypotensive activities of Thioproperazine.
Thioridazine
The metabolism of Bisoprolol can be decreased when combined with Thioridazine.
Tiaprofenic Acid
Tiaprofenic acid may decrease the antihypertensive activities of Bisoprolol.
Tibolone
Bisoprolol may increase the hypotensive activities of Tibolone.
Ticlopidine
The metabolism of Bisoprolol can be decreased when combined with Ticlopidine.
Timolol
Timolol may increase the hypotensive activities of Bisoprolol.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Bisoprolol.
Tipranavir
The metabolism of Bisoprolol can be decreased when combined with Tipranavir.
Tizanidine
Tizanidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Tocilizumab
The serum concentration of Bisoprolol can be decreased when it is combined with Tocilizumab.
Tofacitinib
Tofacitinib may increase the bradycardic activities of Bisoprolol.
Tolazamide
Bisoprolol may increase the hypoglycemic activities of Tolazamide.
Tolazoline
Bisoprolol may increase the orthostatic hypotensive activities of Tolazoline.
Tolbutamide
Bisoprolol may increase the hypoglycemic activities of Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Bisoprolol.
Tolfenamic Acid
Tolfenamic Acid may decrease the antihypertensive activities of Bisoprolol.
Tolmetin
Tolmetin may decrease the antihypertensive activities of Bisoprolol.
Toloxatone
Toloxatone may increase the hypotensive activities of Bisoprolol.
Torsemide
Torasemide may increase the hypotensive activities of Bisoprolol.
Trandolapril
Trandolapril may increase the hypotensive activities of Bisoprolol.
Tranilast
Tranilast may decrease the antihypertensive activities of Bisoprolol.
Tranylcypromine
The metabolism of Bisoprolol can be decreased when combined with Tranylcypromine.
Travoprost
Travoprost may increase the hypotensive activities of Bisoprolol.
Trazodone
Bisoprolol may increase the orthostatic hypotensive activities of Trazodone.
Treprostinil
Treprostinil may increase the hypotensive activities of Bisoprolol.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Bisoprolol.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Bisoprolol.
Tribenoside
Tribenoside may decrease the antihypertensive activities of Bisoprolol.
Trichlormethiazide
Bisoprolol may increase the hypotensive activities of Trichlormethiazide.
Trifluoperazine
Bisoprolol may increase the orthostatic hypotensive activities of Trifluoperazine.
Triflupromazine
Triflupromazine may increase the hypotensive activities of Bisoprolol.
Trimeprazine
Alimemazine may increase the hypotensive activities of Bisoprolol.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Bisoprolol.
Trimipramine
Bisoprolol may increase the orthostatic hypotensive activities of Trimipramine.
Tubocurarine
Tubocurarine may increase the bradycardic activities of Bisoprolol.
Tyrothricin
Tyrothricin may increase the bradycardic activities of Bisoprolol.
UNOPROSTONE
Bisoprolol may increase the hypotensive activities of Unoprostone.
Urapidil
Bisoprolol may increase the orthostatic hypotensive activities of Urapidil.
Valdecoxib
Valdecoxib may decrease the antihypertensive activities of Bisoprolol.
Valsartan
Valsartan may increase the hypotensive activities of Bisoprolol.
Vardenafil
Vardenafil may increase the antihypertensive activities of Bisoprolol.
Varenicline
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Varenicline.
Vemurafenib
The serum concentration of Bisoprolol can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Bisoprolol can be decreased when combined with Venlafaxine.
Verapamil
Bisoprolol may increase the orthostatic hypotensive activities of Verapamil.
Vilanterol
Bisoprolol may decrease the bronchodilatory activities of Vilanterol.
Vincamine
Bisoprolol may increase the hypotensive activities of Vincamine.
Vinpocetine
Bisoprolol may increase the hypotensive activities of Vinpocetine.
Voriconazole
The metabolism of Bisoprolol can be decreased when combined with Voriconazole.
Xylazine
Xylazine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Xylometazoline
Xylometazoline may increase the atrioventricular blocking (AV block) activities of Bisoprolol.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Bisoprolol.
Zileuton
Zileuton may decrease the antihypertensive activities of Bisoprolol.
Ziprasidone
Bisoprolol may increase the orthostatic hypotensive activities of Ziprasidone.
Zofenopril
Bisoprolol may increase the hypotensive activities of Zofenopril.
Zomepirac
Zomepirac may decrease the antihypertensive activities of Bisoprolol.
Zuclopenthixol
Bisoprolol may increase the orthostatic hypotensive activities of Zuclopenthixol.
